ScholarIQanswers from OpenAlex

Immunotherapy in Renal Cell Carcinoma: The Future Is Now

PaperCitations, authors & open-access status

Immunotherapy in Renal Cell Carcinoma: The Future Is Now is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Immunotherapy in Renal Cell Carcinoma: The Future Is Now have?

ScholarIQcitation count

Immunotherapy in Renal Cell Carcinoma: The Future Is Now has 224 citations in the OpenAlex counts ScholarIQ stores.

When was Immunotherapy in Renal Cell Carcinoma: The Future Is Now published?

ScholarIQyear

Immunotherapy in Renal Cell Carcinoma: The Future Is Now has 2020 year in the ScholarIQ index.

What is the open-access status of Immunotherapy in Renal Cell Carcinoma: The Future Is Now?

ScholarIQoa status

Immunotherapy in Renal Cell Carcinoma: The Future Is Now has gold oa status in the ScholarIQ index.

What is the DOI of Immunotherapy in Renal Cell Carcinoma: The Future Is Now?

ScholarIQdoi

The DOI for Immunotherapy in Renal Cell Carcinoma: The Future Is Now is on the source record.

What is the PMID of Immunotherapy in Renal Cell Carcinoma: The Future Is Now?

ScholarIQpmid

The PMID for Immunotherapy in Renal Cell Carcinoma: The Future Is Now is on the source record.

What is the OpenAlex record for Immunotherapy in Renal Cell Carcinoma: The Future Is Now?

ScholarIQopenalex

The OpenAlex for Immunotherapy in Renal Cell Carcinoma: The Future Is Now is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial